SCHEMBL6237741

SCHEMBL6237741

NC(=O)CN(O)CCc1cc2ccccc2s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.49
ASIC3 Q9UHC3 1/20 0.49
LOXL2 Q9Y4K0 1/20 0.49
AGXT P21549 1/20 0.45
ALOX5 P09917 5/20 0.44
CYP1A2 P05177 2/20 0.44
PTGES O14684 1/20 0.44
LMNA P02545 1/20 0.44
LTA4H P09960 1/20 0.44
GAA P10253 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
ALOX5AP P20292 1/20 0.44
LOX P28300 1/20 0.44
EPHX2 P34913 1/20 0.44
PTGS2 P35354 1/20 0.44
LTB4R Q15722 1/20 0.44
ADRB2 P07550 1/20 0.42
SLC9A1 P19634 1/20 0.41
BCL2L1 Q07817 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL436458 0.82 CYP2A6 (0.51) CYP2A6ASIC3LOXL2AGXTALOX5
SCHEMBL1445507 0.78 CYP2A6 (0.53) CYP2A6ASIC3LOXL2AGXTALOX5
SCHEMBL1029348 0.77 CYP2A6 (0.59) CYP2A6ASIC3LOXL2AGXTALOX5
SCHEMBL6344125 0.77 CYP2A6 (0.51) CYP2A6ASIC3LOXL2AGXTALOX5
Ammonia Solution, Strong SCHEMBL6237737 0.75 CYP2A6 (0.50) CYP2A6ASIC3LOXL2AGXTALOX5
SCHEMBL4847281 0.75 CYP2A6 (0.56) CYP2A6ASIC3LOXL2AGXTADRB2
SCHEMBL1444688 0.74 CYP2A6 (0.51) CYP2A6ASIC3LOXL2AGXTALOX5
SCHEMBL2396391 0.73 CYP2A6 (0.54) CYP2A6ASIC3LOXL2AGXTALOX5
SCHEMBL4510014 0.72 CYP2A6 (0.58) CYP2A6ASIC3LOXL2AGXTALOX15
SCHEMBL1444257 0.71 CYP2A6 (0.45) CYP2A6ASIC3LOXL2AGXTALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005011613-A2 COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A LIPOXYGENASE INHIBITOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE EPIGENESIS PHARMACEUTICALS LLC (US) 2005-02-10 WO disclosed